View in EDS

Author Correction: Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial.

Saved in:
Bibliographic Details
Title: Author Correction: Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial.
Authors: Raab MS; Heidelberg Myeloma Center and GMMG Study Group, Department of Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany. marc.raab@med.uni-heidelberg.de., Weinhold N; Heidelberg Myeloma Center and GMMG Study Group, Department of Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany., Kortüm KM; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany., Krönke J; Department of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Berlin, Berlin, Germany., Fenk R; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Weisel K; University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Podola L; Heidelberg Myeloma Center and GMMG Study Group, Department of Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany., Bertsch U; Heidelberg Myeloma Center and GMMG Study Group, Department of Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany., Brobeil A; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Mersi J; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany., Huhn S; Heidelberg Myeloma Center and GMMG Study Group, Department of Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany., Arlinghaus R; Coordination Centre for Clinical Trials (KKS), University Hospital Heidelberg, Heidelberg, Germany., Hundemer M; Heidelberg Myeloma Center and GMMG Study Group, Department of Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany., Bohl SR; Department of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Mai EK; Heidelberg Myeloma Center and GMMG Study Group, Department of Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany., Schub N; Department of Internal Medicine II, Division of Stem Cell Transplantation and Immunotherapy, Universitätsklinikum Schleswig-Holstein (UKSH) Campus Kiel, Kiel, Germany., Waldschmidt J; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany., Bassermann F; Department of Medicine III, TUM Klinikum, Technische Universität München, München, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany.; Bayerisches Zentrum für Krebsforschung (BZKF), Munich, Germany., Müller-Tidow C; Heidelberg Myeloma Center and GMMG Study Group, Department of Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany., Heuck C; Johnson & Johnson, Spring House, PA, USA., Sakabedoyan C; Johnson & Johnson, Paris, France., Khan J; Johnson & Johnson, High Wycombe, UK., Ershova E; Johnson & Johnson, Beerse, Belgium., Koster BD; Johnson & Johnson, Leiden, The Netherlands., Engelhardt M; Department of Hematology, Oncology and Stem Cell Transplantation, Medical Centre - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Hänel M; Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany., Salwender H; Asklepios Tumorzentrum Hamburg, Asklepios Klinik Altona and Asklepios Klinik St. Georg, Hamburg, Germany., Teipel R; Medizinische Klinik und Poliklinik I Universitätsklinikum Carl Gustav Carus an der Technische Universität Dresden, Dresden, Germany., Goldschmidt H; Heidelberg Myeloma Center and GMMG Study Group, Department of Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany., Einsele H; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany., Rasche L; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany. Rasche_L@ukw.de.
Corporate Authors: GMMG-HD10/DSMM-XX (MajesTEC-5) investigators
Source: Nature medicine [Nat Med] 2026 Jul; Vol. 32 (7), pp. 2688.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42410053
AccessLevel: 2
PubTypeId: unknown
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Author Correction: Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Raab+MS%22">Raab MS</searchLink>; Heidelberg Myeloma Center and GMMG Study Group, Department of Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany. marc.raab@med.uni-heidelberg.de.<br /><searchLink fieldCode="AU" term="%22Weinhold+N%22">Weinhold N</searchLink>; Heidelberg Myeloma Center and GMMG Study Group, Department of Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Kortüm+KM%22">Kortüm KM</searchLink>; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Krönke+J%22">Krönke J</searchLink>; Department of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Fenk+R%22">Fenk R</searchLink>; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.<br /><searchLink fieldCode="AU" term="%22Weisel+K%22">Weisel K</searchLink>; University Medical Center Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Podola+L%22">Podola L</searchLink>; Heidelberg Myeloma Center and GMMG Study Group, Department of Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Bertsch+U%22">Bertsch U</searchLink>; Heidelberg Myeloma Center and GMMG Study Group, Department of Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Brobeil+A%22">Brobeil A</searchLink>; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Mersi+J%22">Mersi J</searchLink>; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Huhn+S%22">Huhn S</searchLink>; Heidelberg Myeloma Center and GMMG Study Group, Department of Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Arlinghaus+R%22">Arlinghaus R</searchLink>; Coordination Centre for Clinical Trials (KKS), University Hospital Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Hundemer+M%22">Hundemer M</searchLink>; Heidelberg Myeloma Center and GMMG Study Group, Department of Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Bohl+SR%22">Bohl SR</searchLink>; Department of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Mai+EK%22">Mai EK</searchLink>; Heidelberg Myeloma Center and GMMG Study Group, Department of Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Schub+N%22">Schub N</searchLink>; Department of Internal Medicine II, Division of Stem Cell Transplantation and Immunotherapy, Universitätsklinikum Schleswig-Holstein (UKSH) Campus Kiel, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Waldschmidt+J%22">Waldschmidt J</searchLink>; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Bassermann+F%22">Bassermann F</searchLink>; Department of Medicine III, TUM Klinikum, Technische Universität München, München, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany.; Bayerisches Zentrum für Krebsforschung (BZKF), Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Müller-Tidow+C%22">Müller-Tidow C</searchLink>; Heidelberg Myeloma Center and GMMG Study Group, Department of Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Heuck+C%22">Heuck C</searchLink>; Johnson & Johnson, Spring House, PA, USA.<br /><searchLink fieldCode="AU" term="%22Sakabedoyan+C%22">Sakabedoyan C</searchLink>; Johnson & Johnson, Paris, France.<br /><searchLink fieldCode="AU" term="%22Khan+J%22">Khan J</searchLink>; Johnson & Johnson, High Wycombe, UK.<br /><searchLink fieldCode="AU" term="%22Ershova+E%22">Ershova E</searchLink>; Johnson & Johnson, Beerse, Belgium.<br /><searchLink fieldCode="AU" term="%22Koster+BD%22">Koster BD</searchLink>; Johnson & Johnson, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Engelhardt+M%22">Engelhardt M</searchLink>; Department of Hematology, Oncology and Stem Cell Transplantation, Medical Centre - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.<br /><searchLink fieldCode="AU" term="%22Hänel+M%22">Hänel M</searchLink>; Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany.<br /><searchLink fieldCode="AU" term="%22Salwender+H%22">Salwender H</searchLink>; Asklepios Tumorzentrum Hamburg, Asklepios Klinik Altona and Asklepios Klinik St. Georg, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Teipel+R%22">Teipel R</searchLink>; Medizinische Klinik und Poliklinik I Universitätsklinikum Carl Gustav Carus an der Technische Universität Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Goldschmidt+H%22">Goldschmidt H</searchLink>; Heidelberg Myeloma Center and GMMG Study Group, Department of Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Einsele+H%22">Einsele H</searchLink>; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Rasche+L%22">Rasche L</searchLink>; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany. Rasche_L@ukw.de.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22GMMG-HD10%2FDSMM-XX+%28MajesTEC-5%29+investigators%22">GMMG-HD10/DSMM-XX (MajesTEC-5) investigators</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229502015%22">Nature medicine</searchLink> [Nat Med] 2026 Jul; Vol. 32 (7), pp. 2688.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Published Erratum
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Company%22">Nature Publishing Company </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502015 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1546-170X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210788956%22">10788956 </searchLink><i>NLM ISO Abbreviation: </i>Nat Med <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42410053
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41591-026-04551-y
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2688
    Titles:
      – TitleFull: Author Correction: Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Raab MS
      – PersonEntity:
          Name:
            NameFull: Weinhold N
      – PersonEntity:
          Name:
            NameFull: Kortüm KM
      – PersonEntity:
          Name:
            NameFull: Krönke J
      – PersonEntity:
          Name:
            NameFull: Fenk R
      – PersonEntity:
          Name:
            NameFull: Weisel K
      – PersonEntity:
          Name:
            NameFull: Podola L
      – PersonEntity:
          Name:
            NameFull: Bertsch U
      – PersonEntity:
          Name:
            NameFull: Brobeil A
      – PersonEntity:
          Name:
            NameFull: Mersi J
      – PersonEntity:
          Name:
            NameFull: Huhn S
      – PersonEntity:
          Name:
            NameFull: Arlinghaus R
      – PersonEntity:
          Name:
            NameFull: Hundemer M
      – PersonEntity:
          Name:
            NameFull: Bohl SR
      – PersonEntity:
          Name:
            NameFull: Mai EK
      – PersonEntity:
          Name:
            NameFull: Schub N
      – PersonEntity:
          Name:
            NameFull: Waldschmidt J
      – PersonEntity:
          Name:
            NameFull: Bassermann F
      – PersonEntity:
          Name:
            NameFull: Müller-Tidow C
      – PersonEntity:
          Name:
            NameFull: Heuck C
      – PersonEntity:
          Name:
            NameFull: Sakabedoyan C
      – PersonEntity:
          Name:
            NameFull: Khan J
      – PersonEntity:
          Name:
            NameFull: Ershova E
      – PersonEntity:
          Name:
            NameFull: Koster BD
      – PersonEntity:
          Name:
            NameFull: Engelhardt M
      – PersonEntity:
          Name:
            NameFull: Hänel M
      – PersonEntity:
          Name:
            NameFull: Salwender H
      – PersonEntity:
          Name:
            NameFull: Teipel R
      – PersonEntity:
          Name:
            NameFull: Goldschmidt H
      – PersonEntity:
          Name:
            NameFull: Einsele H
      – PersonEntity:
          Name:
            NameFull: Rasche L
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2026 Jul
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1546-170X
          Numbering:
            – Type: volume
              Value: 32
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Nature medicine
              Type: main
ResultId 1